Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Risk Factors of Ectopic Pregnancy
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: University of Pennsylvania
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by: University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00194207
  Purpose

The purpose of this study is to identify elements of a patient's demographics, history, and clinical presentation that may aid in differentiating between patients with an ectopic pregnancy, miscarriage, or normal intrauterine pregnancy. This study will also evaluate serial levels of human chorionic gonadotropin in the serum of these patients, as another way to make the diagnosis.


Condition
Ectopic Pregnancy

Genetics Home Reference related topics: Brugada syndrome short QT syndrome
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Risk Factors as Predictors of Ectopic PRegnancy

Further study details as provided by University of Pennsylvania:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Serum


Estimated Enrollment: 3000
Study Start Date: October 1999
Estimated Study Completion Date: March 2010
Detailed Description:

The backbone of this protocol is the systematic evaluation of the presentation, work up, diagnosis and treatment outcome of women who present for evaluation of pain or bleeding in the first trimester of pregnancy and are therefore at risk for ectopic pregnancy (EP). Our focus is women whose diagnosis was not definitive upon initial presentation. We plan to collect systematic data regarding the current diagnostic strategies and treatment of these women and compare actual outcomes to those predicted by our newly developed strategies. This will be the first time such an endeavor has been conducted at multiple centers concomitantly. Expansion to two other sites is vital to ensure our preliminary data is valid and generalizable to women from different races and ethnicities, as well as to achieve the precision necessary to develop an accurate clinical tool. We will use a secure web-based clinical database (the Quantbook) to compile clinical information, and will download de-identified data to the research database once the diagnosis and clinical course of a patient has been completed. The Quantbook will be an expansion of a clinical database successfully utilized at Penn for the past 15 years. For a more detailed description of the Quantbook and research databases please see Attachment 2 of the full protocol. High quality information obtained from this cohort of women will allow the optimization and validation of our currently derived and proposed methods of diagnosis.

Data Collection Clinical Database (Quantbook): The clinician (e.g., attending physician, fellow, resident physician, nurse practitioner) who assesses the patient input information into the Quantbook. At the first presentation, this will include the patient's medical history, as well as presenting signs and symptoms. Results of tests ordered, including hCG and relevant chemistry, hematology, blood type, and ultrasound, will be entered. The clinician will assign a clinical impression (which may be a final definitive diagnosis, or a suspected diagnosis, or "unable to determine"). Follow-up contacts and assessments are recorded as they occur. Each time the patient returns for an assessment, the clinical impression can be updated, until a definitive diagnosis is made. A research coodinator will be tasked to monitor the Quantbook to provide quality control that the clinical data entered is complete and correct.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women with early pregnancy with symptoms of pain and bleeding, presenting to the ER at the Hospital of University of Pennsylvania

Criteria

Inclusion Criteria:

  • Reproductive-aged women
  • Currently pregnant based on serum human chorionic gonadotropin test
  • Present for care for vaginal bleeding and/or pelvic pain
  • Final diagnosis of:

    1. Ectopic pregnancy
    2. Miscarriage less than 14 weeks gestation
    3. Ongoing normal intrauterine pregnancy less than 14 weeks gestation
  • Entered into clinical tracking database

Exclusion Criteria:

  • Patients not entered in clinical tracking database, or with insufficient information recorded to analyze (e.g. missing final diagnosis)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00194207

Locations
United States, Pennsylvania
University of Pennsylvania Reproductive Research Unit
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: Kurt T Barnhart, MD, MSCE University of Pennsylvania
  More Information

Responsible Party: University of Pennsylvani ( Kurt T Barnhart, MD, MSCE )
Study ID Numbers: 103700, RO1-HD-36455-01A1
Study First Received: September 13, 2005
Last Updated: July 26, 2008
ClinicalTrials.gov Identifier: NCT00194207  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pennsylvania:
ectopic pregnancy

Study placed in the following topic categories:
Heart Diseases
Pregnancy Complications
Pregnancy, Ectopic
Ectopic pregnancy
Cardiac Complexes, Premature
Arrhythmias, Cardiac

Additional relevant MeSH terms:
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009